|
Brian Lundstrom has served as our Senior Vice President, Business Development since November 2004. Prior to joining us, Mr. Lundstrom held the position of Vice President, Business Development at Genzyme Corporation where he led the integration and outlicensing of assets from SangStat Medical Corporation that he had joined in 2000 and helped grow through partnering until sale of the company to Genzyme in 2003. Earlier in his career, Mr. Lundstrom held increasingly senior business, clinical and product development positions with discovery-based and commercially operating Oxford GlycoSciences (1998-2000), Novo Nordisk (1990-1997) and Immuntech (1986-1989). Mr. Lundstrom has negotiated over 40 deals on discovery technologies, clinical-stage product candidates and marketed products. He holds an M.S. in biotechnology from the Danish Technical University and an MBA equivalent degree in international business and finance from Copenhagen Business School and Seattle University. | 